MARKET

BIB

BIB

ProShares Ultra Nasdaq Biotechnology
NASDAQ

Real-time Quotes | Provided by Morningstar

61.14
+1.13
+1.88%
Closed 16:00 12/06 EST
OPEN
60.73
PREV CLOSE
60.01
HIGH
61.50
LOW
60.25
VOLUME
152.76K
TURNOVER
--
52 WEEK HIGH
61.78
52 WEEK LOW
36.05
TOTAL ASSET
191.76M
YTD YIELD
41.31%
1D
5D
1M
3M
1Y
5Y

Tools for In-Depth Analysis of BIB, Buy or Sell Stocks and ETFs Commission-Free!

Open a Webull account and fund it to get a free stock

BIB News

  • Boston nonprofit playing big role in drug pricing
  • Seeking Alpha - Article.11/04 18:44
  • Drug shortages reflect "broken market" - FDA
  • Seeking Alpha - Article.10/29 16:22
  • Pelosi drug bill passes first House committee
  • Seeking Alpha - Article.10/17 18:13
  • Pelosi drug bill would save $345B - CBO
  • Seeking Alpha - Article.10/15 18:29

More

Profile

Fund Name
ProShares Ultra Nasdaq Biotechnology
Inception Date
2010-04-06
Benchmark
NASDAQ Biotechnology TR USD*200.0%
Advisor Company
ProShares
Custodian
JPMorgan
Manager
Michael Neches, Devin Sullivan, Tarak Davé

Asset Allocation

225.95M
  • 114.2279%
  • 0.00%
  • -98.7024%
  • 84.4745%

2019 Q2

225.95M

2019 Q1

246.55M

2018 Q4

220.49M

2018 Q3

407.78M

2018 Q2

340.25M

Dividend History

Ex-Div Date
Dividend Per Share
09/21/2010
0.0110